Sep 1, 2021 05:24PM
Sep 1, 2021 05:24PM
Aug 5, 2021 04:02PM
Aug 5, 2021 04:02PM
Aug 5, 2021 04:01PM
Aug 5, 2021 04:01PM
Aug 4, 2021 08:30AM Oyster Point Pharma to Report Second Quarter 2021 Financial Results on August 5, 2021
Aug 4, 2021 08:30AM
Aug 2, 2021 04:10PM
Aug 2, 2021 04:10PM
Aug 2, 2021 04:01PM
Aug 2, 2021 04:01PM
Aug 2, 2021 04:01PM
Jul 1, 2021 06:18AM Oyster Point Pharma (OYST) Announces Preclinical Data Highlighting Potent Activity of OC-01 (varenicline) and OC-02 (simpinicline) Against SARS-CoV-2 Virus and Variants
Jul 1, 2021 06:00AM
Jul 1, 2021 06:00AM
Jun 29, 2021 04:46PM
Jun 29, 2021 04:42PM
Jun 29, 2021 04:42PM
Jun 21, 2021 07:00AM
Jun 21, 2021 07:00AM Oyster Point Pharma Announces Enrollment of First Subject in the OLYMPIA Phase 2 Clinical Trial of OC-01 (varenicline) Nasal Spray for Patients with Neurotrophic Keratopathy
Jun 10, 2021 07:02AM
Jun 10, 2021 07:00AM
Jun 10, 2021 07:00AM
Jun 10, 2021 07:00AM
Jun 3, 2021 08:01AM
Jun 3, 2021 08:00AM
Jun 3, 2021 08:00AM Oyster Point Pharma Announces Preclinical Study Results and Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ocular Surface Diseases
May 6, 2021 04:01PM
May 6, 2021 04:01PM
Mar 2, 2021 06:05AM
Mar 2, 2021 06:00AM
Mar 2, 2021 06:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All